Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/22/19 → 2/22/22 |
Funding
- Syneos Health, Inc. (Prot. CP40617)
- Genentech, Inc. (Prot. CP40617)
Prot. CP40617 - A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Assess the Efficacy and Safety of Baloxavir Marboxil in Combination with a Neuraminidase Inhibitor versus a Neuraminidase Inhibitor Alone in Hospitalized Patien
- Ison, Michael G (PD/PI)
Project: Research project